The size of the Clinical Nutrition market in Europe was worth USD 3.56 Billion in 2020 and estimated to be growing at a CAGR of 7.17 % to reach USD 5.03 Billion by 2025. The European clinical nutrition market is driven by the aging population and increased disease diagnosis.
Clinical nutrition products comprise of dietary supplements and clinical foods that are characterized primarily as pharmaceuticals and are distributed through enteral and parenteral feeding. These products are aimed at treating nutritional and metabolic disorders. There is also a good demand for clinical foods for the pediatric population.
Factors boosting the clinical nutrition market growth in the European region are increased preterm birth rates, increased level of health-conscious population, and government initiatives. The positive influence of rising global baby boomers population is predicted to remain medium in the next few years as with refining health standards, and the life anticipation is expected to increase.
The market is highly constrained due to strict FDA regulations and market volatility.
This research report segmented and sub-segmented into the following categories:
Based on product type, Enteral nutrition is the product type segment with the highest share in the market.
Regionally, France is expected to grow at the highest CAGR in the forecast period while the U.K dominates the clinical nutrition market in the European region.
Notable companies operating in the Europe Clinical Nutrition Market profiled in this report are Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H. J. Heinz Company, American Home Patient Inc. and Fresenius Kabi.
This report offers:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Route of Administration
5.1.1 Oral Nutrition
5.1.2 Enteral Nutrition
5.1.3 Parenteral Nutrition
5.2 By Therapeutic Area
5.2.1 Malabsorption
5.2.2 Diarrhoea
5.2.3 Cancer
5.2.4 Food Allergies
5.2.5 Maldigestion
5.2.6 Diabetes
5.2.7 Short-Bowel Syndrome
5.2.8 Acute Lung Injury
5.2.9 Acute Respiratory Distress
5.3 By Ingredients Type
5.3.1 Vitamins
5.3.2 Minerals
5.3.3 Carbohydrates
5.3.4 Amino Acids
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Nestle Nutrition
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Abbott Laboratories Inc.
8.3 Gentiva Health Services Inc.
8.4 Mead Johnson & Company
8.5 Kendall
8.6 Ajinomoto Co. Inc.
8.7 Hospira Inc.
8.8 Hero Nutritionals Inc.
8.9 Lonza Ltd
8.10 Baxter International Inc.
8.11 B. Braun Melsungen AG
8.12 H. J. Heinz Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
